224 related articles for article (PubMed ID: 26233958)
1. MiR-17-92 cluster promotes hepatocarcinogenesis.
Zhu H; Han C; Wu T
Carcinogenesis; 2015 Oct; 36(10):1213-22. PubMed ID: 26233958
[TBL] [Abstract][Full Text] [Related]
2. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice.
Cheng L; Zhu Y; Han H; Zhang Q; Cui K; Shen H; Zhang J; Yan J; Prochownik E; Li Y
Cell Death Dis; 2017 Jul; 8(7):e2916. PubMed ID: 28703810
[TBL] [Abstract][Full Text] [Related]
4. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
5. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
6. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
9. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q
Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114
[TBL] [Abstract][Full Text] [Related]
10. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
Zhang Q; Zhao S; Pang X; Chi B
Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
[TBL] [Abstract][Full Text] [Related]
13. Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.
Kido T; Tabatabai ZL; Chen X; Lau YC
Cancer Sci; 2020 Aug; 111(8):2987-2999. PubMed ID: 32473614
[TBL] [Abstract][Full Text] [Related]
14. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
16. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
[TBL] [Abstract][Full Text] [Related]
17. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma.
Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J
Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
[TBL] [Abstract][Full Text] [Related]
19. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
20. PRAS40 hyperexpression promotes hepatocarcinogenesis.
Qi Z; Zhang T; Song L; Fu H; Luo H; Wu J; Zhao S; Zhang T; Guo L; Jin L; Zhang H; Huang G; Ma T; Wu Y; Huang L
EBioMedicine; 2020 Jan; 51():102604. PubMed ID: 31901857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
